BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Felldin M, Andersson B, Studahl M, Svennerholm B, Friman V. Antibody persistence 1 year after pandemic H1N1 2009 influenza vaccination and immunogenicity of subsequent seasonal influenza vaccine among adult organ transplant patients. Transpl Int 2014;27:197-203. [DOI: 10.1111/tri.12237] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Chong AHW, Mitchell RE, Hemani G, Davey Smith G, Yolken RH, Richmond RC, Paternoster L. Genetic Analyses of Common Infections in the Avon Longitudinal Study of Parents and Children Cohort. Front Immunol 2021;12:727457. [PMID: 34804013 DOI: 10.3389/fimmu.2021.727457] [Reference Citation Analysis]
2 Haddadin Z, Krueger K, Thomas LD, Overton ET, Ison M, Halasa N. Alternative strategies of posttransplant influenza vaccination in adult solid organ transplant recipients. Am J Transplant 2021;21:938-49. [PMID: 32885604 DOI: 10.1111/ajt.16295] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 9.5] [Reference Citation Analysis]
3 Mulley WR, Dendle C, Ling JEH, Knight SR. Does vaccination in solid-organ transplant recipients result in adverse immunologic sequelae? A systematic review and meta-analysis. J Heart Lung Transplant. 2018;37:844-852. [PMID: 29609844 DOI: 10.1016/j.healun.2018.03.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 9.0] [Reference Citation Analysis]
4 Hilchey SP, Palshikar MG, Emo JA, Li D, Garigen J, Wang J, Mendelson ES, Cipolla V, Thakar J, Zand MS. Cyclosporine a directly affects human and mouse b cell migration in vitro by disrupting a hIF-1 αdependent, o2 sensing, molecular switch. BMC Immunol 2020;21:13. [PMID: 32183695 DOI: 10.1186/s12865-020-0342-8] [Reference Citation Analysis]
5 Donato-Santana C, Theodoropoulos NM. Immunization of Solid Organ Transplant Candidates and Recipients: A 2018 Update. Infect Dis Clin North Am 2018;32:517-33. [PMID: 30146021 DOI: 10.1016/j.idc.2018.04.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
6 Loebermann M, Fritzsche C, Geerdes-Fenge H, Heijnen E, Kirby D, Reisinger EC. A phase III, open-label, single-arm, study to evaluate the safety and immunogenicity of a trivalent, surface antigen inactivated subunit influenza virus vaccine produced in mammalian cell culture (Optaflu®) in healthy adults. Infection 2019;47:105-9. [PMID: 30298473 DOI: 10.1007/s15010-018-1233-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
7 Gattis S, Yildirim I, Shane AL, Serluco S, Mccracken C, Liverman R. Impact of Pharmacy-Initiated Interventions on Influenza Vaccination Rates in Pediatric Solid Organ Transplant Recipients. Journal of the Pediatric Infectious Diseases Society 2019;8:525-30. [DOI: 10.1093/jpids/piy095] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Trubiano JA, Johnson D, Sohail A, Torresi J. Travel vaccination recommendations and endemic infection risks in solid organ transplantation recipients. J Travel Med. 2016;23:taw058. [PMID: 27625399 DOI: 10.1093/jtm/taw058] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]